Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Gbolahan Bamgbose, PhD
T-cell acute lymphoblastic leukemia (T-ALL) is a rare and aggressive blood cancer. Unlike many other cancers, T-ALL… -
CRI Funded Scientist
Pilar Baldominos Flores, PhD
“Every big problem originates from a small one, and cancers are no exception,” says Dr. Pilar Baldominos… -
CRI Funded Scientist
Manish Ayushman, PhD
CAR T-cell therapy has shown remarkable success in treating blood cancers, but its effectiveness in solid tumors… -
CRI Funded Scientist
Zachary Earley, PhD
In the gut, a special class of immune cells called intestinal intraepithelial lymphocytes (IELs) act as frontline… -
CRI Funded Scientist
Tuoqi Wu, PhD
Dr. Tuoqi Wu is working to improve CAR T-cell therapy, a treatment that has shown promise for… -
CRI Funded Scientist
Anusha Kalbasi, MD
Dr. Anusha Kalbasi is creating a detailed map of how cytokines influence cancer-fighting T cells – information… -
CRI Funded Scientist
Ryan Flynn, MD, PhD
Dr. Ryan Flynn is tackling a major hurdle in cancer treatment: finding unique markers on the surface… -
CRI Funded Scientist
Edward Chuong, PhD
Dr. Edward Chuong is investigating the unexpected role of transposons in shaping immune responses and potentially influencing… -
CRI Funded Scientist
Judith Agudo, PhD
Dr. Judith Agudo is focused on understanding why some cancer cells escape the immune system, even in…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.